$OPXS
Optex Systems Holdings Inc Stock $opxs

$opxs Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000149315224005894 Filed on February 12, 2024

Income Statement

Concept	2024 Q1	2023 Q4
Revenue	$8.523M	$8.077M
YoY Change	110.97%	19.87%
Cost Of Revenue	$5.966M	$5.441M
YoY Change	79.54%	17.06%
Gross Profit	$2.557M	$2.636M
YoY Change	256.62%	26.12%
Gross Profit Margin	30.0%	32.64%
Selling, General & Admin	$1.201M	$935.0K
YoY Change	20.22%	20.33%
% of Gross Profit	46.97%	35.47%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$117.0K	$93.00K
YoY Change	44.44%	8.14%
% of Gross Profit	4.58%	3.53%
Operating Expenses	$1.201M	$935.0K
YoY Change	20.22%	20.33%
Operating Profit	$1.356M	$1.701M
YoY Change	-580.85%	29.55%
Interest Expense	$9.000K	-$24.00K
YoY Change
% of Operating Profit	0.66%	-1.41%
Other Income/Expense, Net
YoY Change
Pretax Income	$1.347M	$1.677M
YoY Change	-577.66%	27.72%
Income Tax	$285.0K	$246.0K
% Of Pretax Income	21.16%	14.67%
Net Earnings	$1.062M	$1.431M
YoY Change	-576.23%	46.47%
Net Earnings / Revenue	12.46%	17.72%
Basic Earnings Per Share	$0.16	$0.06
Diluted Earnings Per Share	$0.16	$0.21
COMMON SHARES
Basic Shares Outstanding	6.824M shares	6.784M shares
Diluted Shares Outstanding	6.823M shares	6.722M shares

Balance Sheet

Concept	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$321.0K	$1.204M
YoY Change	-74.92%	28.91%
Cash & Equivalents	$321.0K	$1.200M
Short-Term Investments
Other Short-Term Assets	$404.0K	$219.0K
YoY Change	62.25%	-33.23%
Inventory	$13.68M	$12.15M
Prepaid Expenses	$404.0K	$219.0K
Receivables	$3.680M	$3.624M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$18.34M	$17.54M
YoY Change	28.53%	31.04%
LONG-TERM ASSETS
Property, Plant & Equipment	$983.0K	$998.0K
YoY Change	0.61%	3.1%
Goodwill
YoY Change
Intangibles	$1.089M	$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.477M	$3.685M
YoY Change	8.45%	-11.99%
Total Long-Term Assets	$5.460M	$4.683M
YoY Change	6.95%	-9.16%
TOTAL ASSETS
Total Short-Term Assets	$18.34M	$17.54M
Total Long-Term Assets	$5.460M	$4.683M
Total Assets	$23.80M	$22.22M
YoY Change	22.84%	19.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.049M	$810.0K
YoY Change	42.99%	14.73%
Accrued Expenses	$1.089M	$1.265M
YoY Change	11.46%	32.05%
Deferred Revenue	$481.0K	$481.0K
YoY Change	47.55%	54.66%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.726M	$4.077M
YoY Change	4.51%	21.05%
LONG-TERM LIABILITIES
Long-Term Debt	$500.0K	$1.000M
YoY Change
Other Long-Term Liabilities	$2.113M	$2.282M
YoY Change	-20.14%	-17.35%
Total Long-Term Liabilities	$2.613M	$3.282M
YoY Change	-1.25%	18.87%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.726M	$4.077M
Total Long-Term Liabilities	$2.613M	$3.282M
Total Liabilities	$7.339M	$7.359M
YoY Change	2.39%	20.07%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.939M	-$6.432M
YoY Change	-44.62%	-26.03%
Common Stock	$21.40M	$21.29M
YoY Change	1.3%	0.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$16.46M	$14.86M
YoY Change
Total Liabilities & Shareholders Equity	$23.80M	$22.22M
YoY Change	22.84%	19.86%

Cashflow Statement

Concept	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	$1.062M	$1.431M
YoY Change	-576.23%	46.47%
Depreciation, Depletion And Amortization	$117.0K	$93.00K
YoY Change	44.44%	8.14%
Cash From Operating Activities	-$1.276M	$1.105M
YoY Change	-382.93%	626.97%
INVESTING ACTIVITIES
Capital Expenditures	$1.139M	$8.000K
YoY Change	1165.56%	-138.1%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$1.139M	-$8.000K
YoY Change	1165.56%	-61.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	363.0K	-207.0K
YoY Change	-2520.0%	-95.26%
NET CHANGE
Cash From Operating Activities	-1.276M	1.105M
Cash From Investing Activities	-1.139M	-8.000K
Cash From Financing Activities	363.0K	-207.0K
Net Change In Cash	-2.052M	890.0K
YoY Change	-693.06%	-121.02%
FREE CASH FLOW
Cash From Operating Activities	-$1.276M	$1.105M
Capital Expenditures	$1.139M	$8.000K
Free Cash Flow	-$2.415M	$1.097M
YoY Change	-768.98%	534.1%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--10-01
CY2023Q4	dei	Entity Central Index Key EntityCentralIndexKey	0001397016
CY2023Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	OPXS	Credit Facility Noncurrent CreditFacilityNoncurrent		usd
CY2023Q1	us-gaap	Interest Expense Other InterestExpenseOther		usd
CY2023Q1	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable		usd
CY2023Q4	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability		usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	OPXS	Product Warranty Accrual Warranty Costs ProductWarrantyAccrualWarrantyCosts		usd
CY2023Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease		usd
CY2023Q4	OPXS	Allocated Home Office Expense AllocatedHomeOfficeExpense		usd
CY2023Q1	OPXS	Allocated Home Office Expense AllocatedHomeOfficeExpense		usd
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P5Y
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P5Y
CY2023Q4	dei	Document Type DocumentType	10-Q
CY2023Q4	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q4	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023Q4	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q4	dei	Entity Registrant Name EntityRegistrantName	OPTEX SYSTEMS HOLDINGS, INC.
CY2023Q4	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q4	dei	Entity File Number EntityFileNumber	001-41644
CY2023Q4	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-0609531
CY2023Q4	dei	Entity Address Address Line1 EntityAddressAddressLine1	1420 Presidential Drive
CY2023Q4	dei	Entity Address City Or Town EntityAddressCityOrTown	Richardson
CY2023Q4	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023Q4	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75081-2439
CY2023Q4	dei	City Area Code CityAreaCode	(972)
CY2023Q4	dei	Local Phone Number LocalPhoneNumber	764-5700
CY2023Q4	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2023Q4	dei	Trading Symbol TradingSymbol	OPXS
CY2023Q4	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q4	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q4	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q4	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q4	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q4	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q4	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6823693	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2373000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1204000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2430000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3624000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	12685000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	12153000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	258000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	336000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	154000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	219000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	17900000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	17536000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	964000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	998000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	887000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	922000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2615000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2740000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	23000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	23000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3525000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3685000	usd
CY2023Q4	us-gaap	Assets Assets	22389000	usd
CY2023Q4	us-gaap	Assets Assets	22219000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1796000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	810000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	625000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	620000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	326000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	247000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	992000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1265000	usd
CY2023Q4	OPXS	Accrued Selling Expense Current AccruedSellingExpenseCurrent	280000	usd
CY2023Q4	OPXS	Accrued Selling Expense Current AccruedSellingExpenseCurrent	336000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	48000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	75000	usd
CY2023Q4	OPXS	Contract Loss Reserves Current ContractLossReservesCurrent	308000	usd
CY2023Q4	OPXS	Contract Loss Reserves Current ContractLossReservesCurrent	243000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	481000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	481000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4856000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4077000	usd
CY2023Q4	OPXS	Credit Facility Noncurrent CreditFacilityNoncurrent	1000000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2156000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2282000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2156000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3282000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	7012000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	7359000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6823693	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6823693	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6763070	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6763070	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	21371000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	21285000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6001000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6432000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	15377000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	14860000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22389000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22219000	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6968000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4040000	usd
CY2023Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5284000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3323000	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	1684000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	717000	usd
CY2023Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1131000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	999000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	553000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-282000	usd
CY2023Q4	us-gaap	Interest Expense Other InterestExpenseOther	7000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	546000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-282000	usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	115000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-59000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	431000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-223000	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6666290	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6537808	shares
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6721661	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6537808	shares
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	431000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-223000	usd
CY2023Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	92000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	81000	usd
CY2023Q4	us-gaap	Share Based Compensation ShareBasedCompensation	113000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	35000	usd
CY2023Q4	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	35000	usd
CY2023Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-59000	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1194000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1303000	usd
CY2023Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	532000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1586000	usd
CY2023Q4	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-78000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	336000	usd
CY2023Q4	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-65000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-79000	usd
CY2023Q4	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	4000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	8000	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	713000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	745000	usd
CY2023Q4	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	79000	usd
CY2023Q4	OPXS	Increase Decrease In Accrued Warranty Costs IncreaseDecreaseInAccruedWarrantyCosts	27000	usd
CY2023Q1	OPXS	Increase Decrease In Accrued Warranty Costs IncreaseDecreaseInAccruedWarrantyCosts	-60000	usd
CY2023Q4	OPXS	Increase Decrease In Accrued Selling Expense IncreaseDecreaseInAccruedSellingExpense	-56000	usd
CY2023Q1	OPXS	Increase Decrease In Accrued Selling Expense IncreaseDecreaseInAccruedSellingExpense	336000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	15000	usd
CY2023Q4	OPXS	Increase Decrease In Contract Loss Reserves IncreaseDecreaseInContractLossReserves	-65000	usd
CY2023Q1	OPXS	Increase Decrease In Contract Loss Reserves IncreaseDecreaseInContractLossReserves	7000	usd
CY2023Q4	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	1823000	usd
CY2023Q1	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	674000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2254000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	451000	usd
CY2023Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	58000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	90000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-58000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-90000	usd
CY2023Q4	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1000000	usd
CY2023Q4	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	27000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	15000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1027000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-15000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1169000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	346000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1204000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	934000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2373000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1280000	usd
CY2023Q4	us-gaap	Interest Paid Net InterestPaidNet	7000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	14860000	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	113000	usd
CY2023Q4	OPXS	Stock Issued During Period Value Vested Performance Based Shares Net Of Withheld Taxes StockIssuedDuringPeriodValueVestedPerformanceBasedSharesNetOfWithheldTaxes	-27000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	12685000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	431000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	15377000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	12408000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	35000	usd
CY2023Q1	OPXS	Stock Issued During Period Value Vested Restricted Stock Units Issued Net Of Tax Withholding StockIssuedDuringPeriodValueVestedRestrictedStockUnitsIssuedNetOfTaxWithholding	-15000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-223000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-223000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	12205000	usd
CY2023Q4	us-gaap	Share Price SharePrice	3.70
CY2023Q4	us-gaap	Share Price SharePrice	4.45
CY2023Q4	us-gaap	Share Price SharePrice	5.35
CY2023Q4	us-gaap	Area Of Land AreaOfLand	93967	sqft
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	8483000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	8211000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	4628000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	4460000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	581000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	489000	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	13692000	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	13160000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1007000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1007000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	12153000	usd
CY2023Q4	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zzGZhwpyZvG1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zQbKQCoTIrpj">Concentration of Credit Risk</span>:</i></b> Optex Systems Holdings’ accounts receivables as of December 31, 2023 consisted of U.S. government agencies (<span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231002__20231231__srt--TitleOfIndividualAxis__custom--USGovernmentAgenciesMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zPcUkUKYIGM8" title="Concentration risk percentage">9</span>%), six major U.S. defense contractors (<span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231002__20231231__srt--TitleOfIndividualAxis__custom--MajorUSDefenseContractorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zTLIGxDRiNW4" title="Concentration risk percentage">25</span>%, <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231002__20231231__srt--TitleOfIndividualAxis__custom--MajorUSDefenseContractorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zWEUu1CIqPkl" title="Concentration risk percentage">7</span>%, <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231002__20231231__srt--TitleOfIndividualAxis__custom--MajorUSDefenseContractorThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zHNrpGp4cqZg" title="Concentration risk percentage">7</span>%, <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231002__20231231__srt--TitleOfIndividualAxis__custom--MajorUSDefenseContractorFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zmactWATvjVd" title="Concentration risk percentage">5</span>%, <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231002__20231231__srt--TitleOfIndividualAxis__custom--MajorUSDefenseContractorFiveMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zaXsmtl0P4p5" title="Concentration risk percentage">5</span>%, and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231002__20231231__srt--TitleOfIndividualAxis__custom--MajorUSDefenseContractorSixMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zJRIheXXQGzf" title="Concentration risk percentage">5</span>%, respectively), one commercial customer (<span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231002__20231231__srt--TitleOfIndividualAxis__custom--OneCommercialCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zC1ORzNU9r8h" title="Concentration risk percentage">18</span>%), one foreign military customer (<span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231002__20231231__srt--TitleOfIndividualAxis__custom--OneForeignMilitaryCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zRd9itKPqXD9" title="Concentration risk percentage">10</span>%) and all other customers (<span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231002__20231231__srt--TitleOfIndividualAxis__custom--AllOtherCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zvTqnpo5lGKi" title="Concentration risk percentage">9</span>%). The Company does not believe that this concentration results in undue credit risk because of the financial strength of the customers and the Company’s long history with these customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	OPXS	Warranty Reserve WarrantyReserve	48000	usd
CY2023Q4	OPXS	Warranty Reserve WarrantyReserve	75000	usd
CY2023Q4	OPXS	Warranty Reserve WarrantyReserve	75000	usd
CY2022Q4	OPXS	Warranty Reserve WarrantyReserve	169000	usd
CY2023Q4	OPXS	Product Warranty Accrual Warranty Costs ProductWarrantyAccrualWarrantyCosts	-32000	usd
CY2023Q4	OPXS	Product Warranty Accrual Reserved For New Product Shipping ProductWarrantyAccrualReservedForNewProductShipping	52000	usd
CY2023Q1	OPXS	Product Warranty Accrual Reserved For New Product Shipping ProductWarrantyAccrualReservedForNewProductShipping	60000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-47000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Period Increase Decrease ProductWarrantyAccrualPeriodIncreaseDecrease	5000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Period Increase Decrease ProductWarrantyAccrualPeriodIncreaseDecrease	60000	usd
CY2023Q4	OPXS	Warranty Reserve WarrantyReserve	48000	usd
CY2023Q1	OPXS	Warranty Reserve WarrantyReserve	229000	usd
CY2023Q4	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_844_eus-gaap--UseOfEstimates_zBFogRgnAuY5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zhiEpMKa2iJ">Use of Estimates</span>: </i></b>The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from the estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	OPXS	Revenue From Customer Deposit Liabilities RevenueFromCustomerDepositLiabilities	0	usd
CY2023Q1	OPXS	Revenue From Customer Deposit Liabilities RevenueFromCustomerDepositLiabilities	29000	usd
CY2023Q4	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	481000	usd
CY2023Q4	OPXS	Accrued Selling Expense Current AccruedSellingExpenseCurrent	280000	usd
CY2023Q4	OPXS	Accrued Selling Expense Current AccruedSellingExpenseCurrent	336000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	258000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	336000	usd
CY2022Q4	OPXS	Contract Value ContractValue	3400000	usd
CY2023Q4	OPXS	Reduction Of Contract Assets And Accrued Selling Expenses ReductionOfContractAssetsAndAccruedSellingExpenses	56000	usd
CY2023Q4	us-gaap	Selling Expense SellingExpense	22000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	481000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	656000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	662000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	679000	usd
CY2023Q4	OPXS	Contract Loss Reserves Current ContractLossReservesCurrent	308000	usd
CY2023Q4	OPXS	Contract Loss Reserves Current ContractLossReservesCurrent	243000	usd
CY2023Q4	OPXS	Loss Reserves On New Contract Awards LossReservesOnNewContractAwards	90000	usd
CY2023Q4	OPXS	Amount Shipped Against Existing Loss Reserves AmountShippedAgainstExistingLossReserves	25000	usd
CY2023Q1	OPXS	Loss Reserves On New Contract Awards LossReservesOnNewContractAwards	51000	usd
CY2023Q1	OPXS	Amount Shipped Against Existing Loss Reserves AmountShippedAgainstExistingLossReserves	58000	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6968000	usd
CY2023Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	92000	usd
CY2023Q4	us-gaap	Interest Expense InterestExpense	7000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	546000	usd
CY2023Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	113000	usd
CY2023Q4	OPXS	Warranty Expense WarrantyExpense	5000	usd
CY2023Q4	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	22389000	usd
CY2023Q4	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	58000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4040000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	81000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-282000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	35000	usd
CY2023Q1	OPXS	Warranty Expense WarrantyExpense	60000	usd
CY2023Q1	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	19373000	usd
CY2023Q1	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	90000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	572000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	83000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3133000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	352000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2781000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2615000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.050	pure
CY2023Q4	OPXS	Lessee Operating Lease Effective Date LesseeOperatingLeaseEffectiveDate	2021-01-11
CY2023Q4	us-gaap	Deferred Rent Credit DeferredRentCredit	166000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	625000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2156000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	40000	shares
CY2023Q2	OPXS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Amortized Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAmortizedGrantDateFairValue	124000	usd
CY2023Q2	OPXS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Amortized Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAmortizedGrantDateFairValue	320000	usd
CY2023Q4	OPXS	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Performance Period Start ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPerformancePeriodStart	2023-10-02
CY2023Q4	OPXS	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Performance Period End ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPerformancePeriodEnd	2028-10-01
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y5M1D
CY2023Q4	OPXS	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Time Steps In Simulation ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeStepsInSimulation	1,365
CY2023Q4	OPXS	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Time Steps Per Year ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeStepsPerYear	252
CY2023Q4	us-gaap	Share Price SharePrice	3.04
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.500	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0337	pure
CY2023Q4	OPXS	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Cost Of Equity ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCostOfEquity	0.115	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2023Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	113000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	35000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	360000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	473000	usd
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6823693	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6823693	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6763070	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6763070	shares

Files In Submission

Name	View Source	Status
0001493152-24-005894-index-headers.html	Edgar Link	pending
0001493152-24-005894-index.html	Edgar Link	pending
0001493152-24-005894.txt	Edgar Link	pending
0001493152-24-005894-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
opxs-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
opxs-20231231_cal.xml	Edgar Link	unprocessable
opxs-20231231_def.xml	Edgar Link	unprocessable
opxs-20231231_lab.xml	Edgar Link	unprocessable
opxs-20231231_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPXS
Optex Systems Holdings Inc Stock $opxs

2024 Q1 Form 10-Q Financial Statement

#000149315224005894 Filed on February 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPXS Optex Systems Holdings Inc Stock $opxs

2024 Q1 Form 10-Q Financial Statement

#000149315224005894 Filed on February 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPXS
Optex Systems Holdings Inc Stock $opxs